Determining Which Patients Will Benefit from GLP-1 RAs: Applying Guidelines and Evidence to Individualize Treatment Decisions in T2DM
0.50 hr(s) | CME
Therapeutic Area(s): Endocrinology
Release Date: July 16, 2021
Expiration Date: July 15, 2022
Location: Internet Activity Enduring
In this activity, an expert on type 2 diabetes mellitus (T2DM) discusses how GLP-1 RAs can be integrated into individualized treatment plans to improve outcomes for patients with T2DM.